CompletedPhase 2NCT03077451
Nelfinavir Mesylate in Treating Patients With Kaposi Sarcoma
Studying Kaposi sarcoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- AIDS Malignancy Consortium
- Principal Investigator
- Soren Gantt, MDAIDS Malignancy Consortium
- Intervention
- Laboratory Biomarker Analysis(other)
- Enrollment
- 36 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2017 – 2023
Study locations (12)
- University of Miami, Miami, Florida, United States
- Emory University/Grady Hospital, Atlanta, Georgia, United States
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
- Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
- Washington University School of Medicine, St Louis, Missouri, United States
- Memorial Sloan Kettering Cancer Center, New York, New York, United States
- Montefiore Medical Center, The Bronx, New York, United States
- Ohio State University, Columbus, Ohio, United States
- Baylor College of Medicine, Houston, Texas, United States
- Benaroya Research Institute at Virginia Mason Medical Center, Seattle, Washington, United States
- African Cancer Institute, Stellenbosch University, Cape Town, South Africa
- Uganda Cancer Institute, Kampala, Uganda
Collaborators
National Cancer Institute (NCI) · The Emmes Company, LLC · University of Arkansas · University of California, Los Angeles · AIDS and Cancer Specimen Resource · Montefiore Medical Center
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03077451 on ClinicalTrials.govOther trials for Kaposi sarcoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT06445166Propranolol for the Treatment of Kaposi Sarcoma in AdultsWashington University School of Medicine
- RECRUITINGNCT06751355Precision Imaging to Evaluate Kaposi Sarcoma (PRIME-KS): A Device Feasibility TrialWashington University School of Medicine
- RECRUITINGNCT06375122Natural History Study of Kaposi SarcomaNational Cancer Institute (NCI)
- RECRUITINGPHASE2NCT04305691Trial of Ixazomib for Kaposi SarcomaAIDS Malignancy Consortium
- ACTIVE NOT RECRUITINGPHASE1NCT05646082Preliminary Assessment of Safety and Tolerability of Dostarlimab in Combination Antiretroviral Therapy (cART) Refractory HIV Associated Kaposi SarcomaImperial College London
- ACTIVE NOT RECRUITINGPHASE2NCT04577755Pomalidomide Treatment in Patients With Kaposi SarcomaNational Cancer Institute (NCI)
- ACTIVE NOT RECRUITINGNANCT04742387Assessment of Bone Mineral Density in People Living With HIV and KSHV Associated Malignancies: A Retrospective Longitudinal AnalysisNational Cancer Institute (NCI)
- RECRUITINGPHASE2NCT03993106A Study of sEphB4-HSA in Kaposi SarcomaVasgene Therapeutics, Inc